Phase III-IV

Bayer taps Clariness to build patient insights into clinical trial review process

13-Sep-2022 By Nick Taylor

Bayer Pharma has enlisted Clariness to support its new study review process by providing pre-clinical trial patient insights and post-trial feedback.

Use of RWE, AI elevating drug development: Sidley

12-Sep-2022 By Jenni Spinner

A fleet of legal professionals offers advice and perspective on important considerations when harnessing artificial intelligence and real-world evidence.

Real-world evidence helps accelerate research: Wolters Kluwer Health

12-Sep-2022 By Jenni Spinner

Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines.

Clarify, Datavant team up to securely connect first-party and real-world data

07-Sep-2022 By Nick Taylor

The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.

CVS Health agrees to acquire Signify Health

06-Sep-2022 By Jenni Spinner

With the purchase, the company is looking to advance its plans to connect with potential trial participants and spread awareness of study participation.

DTRA glossary aims to promote adoption of decentralized format

06-Sep-2022 By Jenni Spinner

The Decentralized Trials and Research Alliance is offering the research resource to increase awareness, understanding, and acceptance of the study format.

Patient-centric approach benefits more than the patient: Quanticate

06-Sep-2022 By Jenni Spinner

A representative from the biometric contract research organization explains how taking a ‘patient comes first’ attitude can lead to a range of improvements.

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Syneos joins with physIQ, InCarda on atrial fibrillation study

30-Aug-2022 By Jenni Spinner

The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.

Charles River opens research facilities in California and Washington

30-Aug-2022 By Jane Byrne

Organization extends turnkey research facility network to San Diego, San Francisco, Thousand Oaks, and Seattle.

Celanese lands Gates Foundation grant for refillable contraceptive research

29-Aug-2022 By Jenni Spinner

The company has landed funding from the Bill and Melinda Gates Foundation for research and development on a prototype of a refillable contraceptive solution.

NIH awards SBIR grant to AVM for lymphoma drug research

25-Aug-2022 By Jenni Spinner

The National Institutes of Health grant to AVM Biotechnology will be used to evaluate a drug to treat non-Hodgkin’s lymphoma combined with standard of care.

BMS forges multi-year research partnership with PathAI

25-Aug-2022 By Jenni Spinner

The pharmaceutical company and the artificial intelligence pathology specialist will focus on translational research in oncology, fibrosis, and immunology.

Include patient voice at every stage of clinical processes: Within3

23-Aug-2022 By Jenni Spinner

A leader suggests considering patient views and needs all along the clinical development path reaps a number of benefits, including time and cost savings.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

American Kidney Fund launches resources to engage patients of color

22-Aug-2022 By Jenni Spinner

The group has introduced a downloadable guide, interactive quiz, and other tools to inform patients from underrepresented communities about trial participation.

Is it time to start rethinking mobile clinical trial apps?

22-Aug-2022 By Jenni Spinner

A leader from the trial financial management specialist suggests apps used in trials could be adjusted to better suit patients, sites and other stakeholders.

BMS expands precision oncology portfolio with Turning Point acquisition

18-Aug-2022 By Jenni Spinner

The pharmaceutical company has completed acquisition of Turning Point Therapeutics, a company specializing in precision medicine solutions for cancer patients.

Merck engages Saama Technologies to build ‘clinical data layer’

18-Aug-2022 By Jenni Spinner

The pharma firm will leverage the ClinTech leader's Life Science Analytics Cloud to bolster development capabilities and accelerate pipeline progress.

Parkinson’s monitoring tech advances in NICE approval process

16-Aug-2022 By Jenni Spinner

The National Institute for Health and Care Excellence is weighing the viability of PD Neurotechnology’s PDMonitor system for Parkinson’s disease patients.

Predictive analytics could unlock precision medicine progress: AiCure

15-Aug-2022 By Jenni Spinner

An expert from the clinical insight specialist shares how predictive analytics could reveal info about medication adherence, disease progression, and more.

Improving patient adherence can elevate trial results: Sweetch

11-Aug-2022 By Jenni Spinner

A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.

Alzheimer’s research data questioned by Department of Justice

09-Aug-2022 By Jenni Spinner

After scientists and reporters raised red flags about a study, Cassava Sciences is being accused of falsifying data in pursuit of an Alzheimer’s treatment.

MCI OneHealth, MDClone team up to use synthetic data to accelerate research

09-Aug-2022 By Nick Taylor

The two companies are collaborating to generate subject data sets designed to help users find insights that can speed up research and improve patient care.

Pfizer to acquire sickle cell disease specialist for $5.4b USD

08-Aug-2022 By Jenni Spinner

Biopharmaceutical company Global Blood Therapeutics specializes in conditions that often disproportionately impact underrepresented communities, such as SCD.

People on the Move: August 2022

04-Aug-2022 By Jenni Spinner

This month’s announcements of appointments, partnerships, expansions, and mergers include Curia, Thread, TFF Pharmaceuticals, and other notable companies.

Medical specialty societies can benefit from regulatory progress: IQVIA

04-Aug-2022 By Jenni Spinner

An expert from the trial tech firm explains how the 21st Century Cures Act and other recent regulatory advancements can elevate clinical data registries.

Boehringer, Seqster ink 3-year health data deal to accelerate research

04-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.

Bilingual staff boost Spanish speaker interest in trials: study

02-Aug-2022 By Nick Taylor

A survey by SubjectWell indicates that having Spanish-speaking research personnel increases interest in trial participation among Latino potential patients.

GCP update: advice on what to expect and how to prepare

01-Aug-2022 By Jenni Spinner

With updates to the Guideline for Good Clinical Practice Advancements on the horizon, an industry expert offers some perspective on what might be ahead.

Curavit, Swing team up on fibromyalgia therapeutic trial

01-Aug-2022 By Nick Taylor

The CRO and DTx specialist are joining forces to conduct a hybrid clinical trial of a potential digital therapeutic that is aimed at treating fibromyalgia.

Investment in decentralized clinical trials pays off: analysis

28-Jul-2022 By Jenni Spinner

A joint study conducted by analysts from Medable and the Center for the Study of Drug Development points toward shorter cycle times, cost savings, and more.

Incorporating patient voice elevates rare-disease trials: Casimir

28-Jul-2022 By Jenni Spinner

During the World Orphan Drug Congress, a co-founder of the CRO outlined how patient perspective can be vital to better results in rare-disease research.

Art contest aims to build awareness of clinical trial opportunities

26-Jul-2022 By Jenni Spinner

Bridging the Gap for Clinical Trials is a free competition designed to employ artistic expression to dispel misinformation start positive conversations.

Cancer Moonshot meeting brings together survivors, industry leaders

26-Jul-2022 By Jenni Spinner

The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Biden’s call to improve screening and treatment options.

Human element important for decentralized trial advancement

25-Jul-2022 By Jenni Spinner

During the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.

Incorporating patient preference vital to study success: ICON

25-Jul-2022 By Jenni Spinner

A leader from the CRO discusses how capturing the perspective of trial participants can help ensure development of treatments that meet the patients’ needs.

Tech Innovations: July 2022

21-Jul-2022 By Jenni Spinner

This month’s announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

Clene links ALS prospect to improved survival in open-label study

21-Jul-2022 By Nick Taylor

The biotechnology company has reported its candidate for treating amyotrophic lateral sclerosis patients has shown promising results in an early-phase study.

Yale, Vanderbilt, Morehouse join to increase trial diversity

21-Jul-2022 By Jenni Spinner

The research institutions are joining on a community-based collaborative initiative to work toward greater study inclusion, supported by funding from PhRMA.

Collaboration sets sights on acceleration of cystic fibrosis research

20-Jul-2022 By Jenni Spinner

Epistemic AI, Cincinnati Children’s Hospital Medical Center, and Boomer Esiason Foundation are working together to advance research into the rare disease.

Worldwide Clinical Trials, Invitae join to accelerate rare-disease studies

19-Jul-2022 By Jenni Spinner

The CRO and medical genetics company will collaborate to accelerate trials centered on rare diseases, using real-world data and genetic testing technology.

Patient advocacy foundation holds listening session with FDA

19-Jul-2022 By Jenni Spinner

The Foundation for Sarcoidosis Research hosted more than 50 agency leaders in a session that addressed patient concerns in research, care, and diagnosis.

Patient voice, empathy key to pediatric study design: ICON

18-Jul-2022 By Jenni Spinner

A pediatric clinical trial expert from the CRO discusses the unique challenges involved in designing a study when the patients involved are little ones.

Online event centers on decentralized study solutions

18-Jul-2022 By Jenni Spinner

Taking place July 20, the Decentralized Trial Technology webinar will share insights and experiences from a group of knowledgeable virtual trial experts.

Recruitment tool pairs pharma firms with providers to boost patient connection

15-Jul-2022 By Jenni Spinner

Clinical Trial Navigator, from AmerisourceBergen, is designed to help sponsors pair with oncology practices to boost patient recruitment opportunities.

False alarms thwart remote patient monitoring early warnings

15-Jul-2022 By Nick Taylor

A study out of Israel's Sheba Medical Center found wearables used to monitor patients can provide early warnings of deterioration, as well as false alarms.

Lymphoma Research Foundation awards $5.7m to pursue blood cancer treatments

12-Jul-2022 By Jenni Spinner

The organization has given 29 research grants to scientists representing 17 different US institutions pursuing lymphoma treatments and cures in their work.

Precision medicine advancements good news for drug development

12-Jul-2022 By Jenni Spinner

A leader from healthcare commercial intelligence company Definitive Healthcare discusses the rise of precision medicine and the benefits the field can yield.